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ABSTRACT 
Oxygen diffusion limitations within nascent tissue engineering scaffolds leads to the 
development of hypoxic regions, cell death, and graft failure. Diffusion limitations are 
most severe in scaling from the mm-sized grafts studied in rodents to the cm-sized grafts 
required for human patients and thus represent a major barrier to clinical translation. 
Extensive efforts have been made to delivery oxygen within tissue engineering scaffolds 
to help maintain cell viability during the period of vascular development and 
anastomosis. Unfortunately, the approaches that have been developed which include 
peroxide-doping, perfluorocarbons, hyperbaric oxygen therapy have lacked 
cytocompatability, oxygen capacity, and practicality, respectively. The outgassing of 
oxygen from hyperbarically loaded polymers represents a novel and elegant solution that 
addresses these shortcomings. Many commonly used biocompatible polymers possess 
high resistance to oxygen diffusion but a non-trivial solubility of oxygen (on the order of 
10% V/V/atm). Thus it is possible to load the polymer with oxygen gas using a 
hyperbaric chamber and to subsequently achieve a prolonged delivery of oxygen as the 
polymer outgasses. By forming microscopic polymeric shells with a hollow core, the 
loading efficiency of oxygen can be greatly enhanced and such a structure is termed a 
microtank. In this thesis, we will describe the development and empirical validation of 
the theory governing the oxygen delivery from hyperbarically loaded materials, including 
microtanks. Oxygen loaded microtanks and/or bulk polymers can be combined with a 
hydrogel phase to form a scaffold with oxygen delivery throughout. This oxygen delivery 
approach has been shown to enhance the survival of human cells cultured under anoxic 
conditions for out to 6 days. Beyond tissue engineering, hyperbaric oxygen loading could 
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be used to functionalize many clinically used polymer implants such as screws, suture 
anchors, stiches, etc. as elevated local oxygen tensions have been shown to enhance 
collagen deposition and reduce infection. Indeed, the biomedical applications are diverse 
and abundant.  
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CHAPTER I:  
 
Biological Requirements for Oxygen within Tissue Engineering 
 
 
Mass transport within tissue engineered grafts 
 Tissue engineered bone, muscle, liver, fat, and blood vessels have all been 
successfully demonstrated in small animal models. These successes are a bellwether 
of the promise of regenerative medicine to revolutionize healthcare by providing 
patient-specific grafts to replace damaged or failing tissue. These reports have 
helped elucidate the underlying mechanisms governing tissue formation and 
provided encouraging proofs-of-concept; however, they often overlook the 
challenges1–4 associated with scaling the grafts from the mm3 domain of mice and 
rats to the cm3 domain of humans. 
 Within small grafts the process of diffusion alone can accommodate the 
transport of nutrients, oxygen, and waste, where as in larger, diffusion-limited 
grafts, convection is required to meet metabolic needs. Unfortunately, convection 
requires functional vascular networks5,6 and these can take several days to weeks to 
form. During this period, cellular metabolic demand exceeds supply leading to 
nutrient deficiency and hypoxia1,7,8, which can ultimately result in cell death and 
graft failure if persistent. 
  2 
 Diffusion limitations apply to all metabolic molecules and can be estimated 
by comparing rates of delivery and/or generation to rates of consumption, as is 
captured in the Thiele modulus9 (1D case): 
    
         
   
 
( I-1 ) 
With scaffold thickness h, cell density      , cellular oxygen uptake rate     , 
Michaelis constant  , and oxygen diffusion constant D. A large Thiele modulus 
indicates diffusion limitations and hence the presence of gradients. Figure I-19 
illustrates how scaffold thickness and cellularity affect the Thiele modulus, 
reproduced from Ebsan, S. et al., 2013.  
 
Figure I-1: Thiele modulus indicates oxygen diffusion limitations within tissue engineered scaffolds. 
(A) Thiele modulus as a function of cell concentration and scaffold thickness, h. (B) Scaffolds of identical 
Thiele moduli illustrating relationship between cell concentration and scaffold thickness. Reproduced from 
Ehsan, S. et al., 2013.9 
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When considering cell metabolism both the deficit of nutrients as well as the 
accumulation of waste products can be problematic10,11. However, in examining the 
equations governing glucose metabolism, the importance of oxygen is highlighted.  
 
Aerobic Metabolism of Glucose: 
 
                             
( I-2 ) 
 
Anaerobic Metabolism of Glucose: 
 
                            
( I-3 ) 
 
If oxygen is present, cellular respiration is able net around 30 ATP per glucose 
molecule and the relatively fast-diffusing CO2 waste product. If oxygen is not 
available anaerobic glycolysis is only able to net 2 ATP plus the relatively slow-
diffusing lactic acid waste product7,12. From the perspective of the Thiele modulus, if 
the energy requirements of the cell are to be maintained then the consumption of 
glucose under anaerobic conditions, Vmax, anaerobic, needs to be 15×Vmax, aerobic. Thus 
the Thiele modulus of glucose under anaerobic conditions is         that of 
aerobic conditions, so diffusion-limitations occur over proportionally shorter 
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distances. This is in addition to the more diffusion-limited and less tolerated waste 
product lactic acid. 
 
3D Finite Difference Models of Nutrient Transport within Grafts 
 In order to understand more precisely the scales at which diffusion 
limitations become important, a computational model of cellular metabolism and 
diffusional mass transport was created. The model employs the finite difference 
method to solve Fick’s laws of diffusion over the scaffold geometry with 
consideration for local cell density, oxygen uptake rate, and diffusion constants. A 
Michaelis-Menten type model was used to predict the cellular oxygen uptake rate 
with parameters obtained from the literature9. A square slab geometry was 
predominantly used with length scales varying from mm to cm to model tissue 
dimensions up to clinically relevant sizes. Typical cell seeding densities for tissue 
engineering constructs were used. The parameters of the model were varied during 
sensitivity analysis, but representative values are as follows: 
 
Diffusion of Oxygen in Hydrogel: DO2 = 1.7×10-9 
Cellular Oxygen Uptake Rate: Vmax = 1.3×10-17 mol/cell/s 
Oxygen Concentration at Half-Maximum OUR: Km = 5.6 mmHg 
Oxygen Solubility in Hydrogel: SO2 = 1.19×10-6 mol/L/mmHg 
Boundary Condition of Oxygen Concentration: CO2, ∞ = 140 mmHg 
Cellular Density within Hydrogel: ρcell = 5×106 cells/mL 
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Michaelis-Menten Equation for Volumetric Oxygen Uptake Rate (OUR):  
 
               
   
      
 
( I-4 ) 
 
Fick’s Second Law of Diffusion:  
 
    
  
   
     
   
 
     
   
 
     
   
  
( I-5 ) 
 
Space and time discretized as: 
 
       
         
     
       
     
 
     
 
       
           
  
 
     
     
( I-6 ) 
 
 The results of the simulation with the aforementioned conditions, illustrated 
how quickly and to what extent diffusion limitations affect tissue engineered grafts. 
Figure I-2 depicts the oxygen concentrations through the central slice of a 
3cm×3cm×1cm hydrogel over a period of 12 hours. Of note, is the rate at which 
hypoxia develops within cm-sized grafts and the relative size of the hypoxic region, 
with oxygen tension dropping below 1% after only 3hrs. Given the strong 
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conditions: a bone-marrow derived mesenchymal stem cell might be happy at an 
oxygen tension of 13mmHg (1.8%)13 where as a cardiomyocyte would find such an 
environment detrimental, preferring something around 46mmHg (6%)14. 
 Within this document the amount of oxygen supplied compared to the 
estimates of cellular demand will be provided where possible. Where references are 
made to normoxia, hypoxia, hyperoxia, and anoxia the following definitions will be 
observed to remain consistent with the field of tissue engineering: 
 
Normoxia – Normal oxygen levels. In reference to ex vivo culture, 20% O2. In 
reference to in vivo contexts, 2-8% O2.  
 
Hypoxia – Deficient oxygen levels. In reference to ex vivo culture, below 20% O2; 
most hypoxia experiments are conducted between 1-5%O2. In reference to in vivo 
contexts, typically below 2% O2.  
 
Hyperoxia – Excessive oxygen  levels. In reference to ex vivo culture, greater than 
20% O2. In reference to in vivo contexts, greater than 8% O2.  
 
Anoxia – Absence of oxygen. In reference to ex vivo culture or in vivo culture, 0% O2.  
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Cell and Tissue Level Response to Hypoxia 
 Oxygen is clearly an important molecule for the metabolic function of the 
mammalian cell, and beyond this role it functions as a potent modulator of cell 
function and wound repair6. Hypoxic environments can have divergent effects on 
cells depending on whether the exposure is acute or chronic. Increased production 
of specific extracellular matrix proteins and enhanced angiogenesis are observed 
effects of acute hypoxic exposure, while reduced cellular respiration and 
proliferation are observed under chronic exposure. Oxygen tension has also been 
shown to direct cell fate. 
 Cellular responses to hypoxia are primarily mediated through the hypoxia 
inducible factor pathway15, although there are non-HIF mediated responses. Briefly, 
the pathway is composed of two transcription factors:  HIF-1α, which contains an 
oxygen-dependent degradation domain that leads to degradation under normoxic 
conditions, and HIF-1β, which is constitutively expressed and dimerizes with 
available HIF-1α to form a basic helix-loop-helix transcription factor that can bind to 
hypoxia-responsive elements to drive gene expression. Thus, when the cell 
experiences hypoxia, the degradation of HIF-1α slows, leading to build up of HIF-1α 
within the cell to drive signaling. Hypoxia-responsive elements have been found to 
drive a large number of metabolic, vascular, and survival genes, including: glucose 
transporter 1, enolase 1, erythropoietin, VEGF, and p2110. 
 Local oxygen concentrations have been demonstrated to direct cellular 
differentiation, notably in bone and cartilage where hypoxia favors the formation of 
cartilage. For example, primary rat osteoblasts16 and human bone marrow derived 
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stem cells17 cultured under hypoxic conditions were inhibited from differentiating 
down to an osteogenic phenotype. Similarly, a study18 that cultured cells from the 
embryonic chick tibial cortex under 35% vs 5% O2 found differentiation towards 
bone under high levels of oxygen and cartilage under low levels. While the use of 
oxygen tension to direct cell fate may be possible, it is exceedingly difficult in 
practice due to the steep gradients that develop within grafts. 
 Within wound healing, acute hypoxia caused by the disruption of local 
vasculature plays an important role during angiogenesis19–21 by inducing expression 
of cytokines, growth factors (e.g. PGDF, VEGF, TGF- β), and matrix molecules 
through the HIF pathway. In addition to hypoxia, HIF-1α has been shown22 to be 
stimulated by pro-inflammatory factors like interleukin-1 shortly after injury. 
However, chronic exposure to hypoxia has been shown to reduce the capacity for 
wound healing processes23 resulting in chronic wounds and sores.  
 
Pathologies Caused by Hypoxia 
 Within tissue engineering, the failure of large grafts is routinely tied to the 
formation of a chronic hypoxic core, which eventually leads to necrosis. Beyond 
tissue engineering hypoxia is indicated in the etiology of a number of pathologies 
including: diabetic ulcers and chronic wounds, renal disease, graft necrosis, 
gangrene, myocardial infarction, cerebrovascular insult, tumors, infections, among 
others. The loss of vasculature perfusion, either by slow regression of the network, 
surgical dissection, or occlusion, prevents cells from receiving adequate oxygen and 
they eventually undergo necrosis. Hypoxia can also lead to compromised ECM 
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production, altered metabolism, reduced nitric oxide production, and increased 
MMP production24. Tissues within a hypoxic state are particularly susceptible to 
infection by opportunistic bacteria due to the suppressed activity of the immune 
system, particularly the respiratory burst response of leukocytes, as it is dependent 
on the conversion of local oxygen to H2O2 and hypochlorite25,26. 
 
Survey of Oxygen Delivery Technologies 
 Given the deleterious consequences of hypoxia within diffusion-limited grafts 
and pathologies, a number of approaches have been investigated to augment oxygen 
supply to maintain cell viability during the period of vascularization and promote 
healing. These have included: hyperbaric oxygen therapy where the patient and/or 
graft is placed in an oxygen enriched environment to enhance the oxygen content 
dissolved in the blood and interstitial fluid24,27–29, perfluorocarbon emulsions which 
utilize the high oxygen solubility properties of these chemicals to enhance diffusion 
rates2,30–33, and various peroxide compounds which generate oxygen during a 
decomposition reaction34–36. While each of these approaches has highlighted the 
benefits of oxygen augmentation, they unfortunately each suffer from limitations in 
terms safety and/or efficacy that have prevented their widespread adoption. The 
following section will explore these approaches in further detail and evaluate their 
advantages, disadvantages, and limitations.  
 Hyperbaric oxygen therapy (HBO) is the oldest and most clinically relevant 
approach available. It involves placing the patient within an oxygen-enriched 
environment for an extended period of time, commonly under hyperbaric 
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conditions (typically, 30-90min, 100% O2, 2.5atm)24, with the aim of increasing the 
oxygen content within the blood and thus increasing the delivery of oxygen to cells. 
HBO is indicated for the following conditions37: air or gas embolism, carbon 
monoxide poisoning, clostridial myositis (gas gangrene), crush injury, compartment 
syndrome and other acute traumatic ischemias,  decompression sickness, 
enhancement of healing in selected problem wounds, exceptional blood loss 
(anemia), intra-cranial abscess, necrotizing soft tissue infections, osteomyelitis 
(refractory), delayed radiation injury (soft tissue and bone), skin grafts and flaps 
(compromised), and thermal burns. Of note is that virtually all of these conditions 
have existing blood vessels through which the oxygen-enriched blood can reach the 
target area. The approach may double or quadruple the effective diffusion distance 
away from capillaries, but this is of little use for avascular grafts. However, HBO has 
been shown to increase vascularization28, partly through the release of endothelial 
progenitor cells from the bone marrow, and improve tissue healing so it may play an 
adjunctive role to help with the engraftment post-implantation. The greatest 
limitation with HBO is that it requires frequent visits to a clinical center, it is an 
intermittent therapy, and it must be administered systemically. 
 Perfluorocarbons are a class of highly fluorinated hydrocarbons liquids with a 
unique capacity for dissolving gases, commonly between 35-55% V/V38 for oxygen. 
They are biologically inert and neither hydrophobic nor hydrophilic due to uniquely 
low intermolecular attractive forces. They are commonly delivered as an emulsion 
into the blood stream with two primary therapeutic effects: firstly, they increase the 
capacity for dissolved oxygen within the blood, and secondly they increase the 
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effective diffusion distance of oxygen by facilitating transport. Unfortunately, in 
many pathologies the reloading of the emulsion as it passes through the lungs is 
negligible. The same can be said within tissue engineering applications where 
oxygen loaded perfluorocarbons contribute only an initial burst of oxygen to the 
graft. The utility of perfluorocarbon emulsions is thus primarily attributable to their 
ability to increase the plasma diffusivity of oxygen, upwards of 10 to 50-fold39, 
although the actual mass movement of O2 does not increase as significantly. This 
effect has been shown to be beneficial in tissue engineered bone grafts31,33 where 
the addition of a 10% PFTBA emulsion doubled bone volume after two weeks in one 
study33. While PFCs may help to reduce oxygen gradients within scaffolds, they do 
are unable to provide a reservoir or a prolonged release of oxygen sufficient to 
nurture cells within nascent tissue engineered grafts. Therefore, PFCs will likely 
only find a role as an adjunct to another oxygen delivery technology. The high cost of 
PFCs also limits their widespread adoption. 
 Peroxide-doped scaffolds rely on the decomposition of calcium peroxide35, 
sodium percarbonate40, among others36, in the presence of water to generate oxygen 
for cellular consumption. This approach benefits from the relatively high density of 
oxygen contained within these materials and the ease of incorporating them into 
various polymeric scaffolds. Oxygen release has been demonstrated over periods of 
4-10 days. The major concern with peroxide-doped scaffolds is the mechanism by 
which the oxygen is generated produces a number of intermediate reactive oxygen 
species and alkali byproducts. For example, calcium peroxide degrades34 to produce 
hydrogen peroxide and calcium hydroxide, then hydroxyl and hydroxide, followed 
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by hydrogen peroxide anion, and then superoxide, before finally producing diatomic 
oxygen. Given that hydrogen peroxide can diffuse effectively 1.5mm within the 
extracellular fluid41 there is concern that the reactive oxygen species could damage 
cells and negate the therapeutic benefit of the oxygen. For example, the reactive 
oxygen species generated from peroxides encapsulated within electrospun fibers 
have been shown to reduce bacterial growth42. Furthermore, the high amount of 
alkali byproduct (2 molecules per O2) could affect pH. 
 Other technologies that have been investigated for oxygen delivery include 
hemoglobin-based oxygen carriers, ultrasonically driven oxygen generators, and 
lipid-stabilized oxygen emulsions. These approaches have demonstrated utility 
within other medical applications but are not suited for the requirements of tissue 
engineering. Thus there remains a significant need for approaches that can safely 
deliver oxygen within grafts over extended periods of time. 
 
Biological and medical consequences of hyperoxia 
 With the discovery of the HIF pathway and its role in the production of VEGF 
to signal vessel ingrowth, it has become widely accepted within the tissue 
engineering community that moderate hypoxia is necessary for infiltration of 
surrounding vasculature into transplanted grafts. Thus there persists concern that 
oxygen delivery technologies will actually hinder vascularization. While there is 
certainly strong evidence to support the role of acute hypoxia in stimulating 
vascular infiltration, it is an error to assume the diametric condition of hyperoxia 
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must therefore inhibit vascularization. In fact, there have been a large number of 
studies that have demonstrated that hyperoxia can stimulate vascular assembly. 
 Hyperoxia is known to enhance wound healing in patients principally by 
stimulating angiogenesis and growth factor production27–29, enhancing fibroblast 
proliferation, improving bactericidal function of leukocyte25,26, increasing collagen 
deposition43–45, reducing edema46, and in cases of systemic hyperoxia mobilizing 
stem progenitor cells from the bone marrow47. With respect to VEGF production, a 
study monitoring the wound environment in rats receiving hyperoxic treatment 
found day 5 levels of VEGF elevated by 40% compared to controls, while lactate 
concentrations remained similar across groups. Maintaining levels of lactate is 
important because it signals the deposition of collagen by fibroblasts. The elevated 
levels of oxygen have been shown to increase the rate of collagen formation, 
specifically through the hydroxylation of proline and lysine. Additional studies have 
found elevated levels of fibroblast growth factor (FGF)48, angiopoeitin 2 (Ang2), and 
platelet derived growth factor receptor (PDGF-R)49. Oxygen delivery does not 
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CHAPTER II:  
 
Theory of Oxygen Delivery Hyperbarically Loaded Materials 
 
 
Diversity of Polymer Properties 
 Polymers are commonly utilized as structural components in tissue 
engineering scaffolds due to their suitable mechanical, biocompatible, and 
degradation properties in addition to being amenable to a number of bench-scale 
additive as well as subtractive manufacturing methodologies. Polymers offer 
incredibly diverse, and tunable physical properties over staggering ranges. 
However, it is important to consider that the vast majority of polymers being 
utilized in tissue engineering were specifically designed, at least initially, for other 
commercial applications and therefore can possess additional properties hereto 
unharnessed by tissue engineers. 
 Consider for example a bottle of Coca-Cola. The requirements for the bottle 
are: resilience against fracture, sufficient mechanical strength to contain pressure 
without deforming, and chemical/hydrolytic resistance to degradation – very 
similar requirements to scaffolds used in certain bone tissue engineering 
applications. In addition, the bottle needs to prevent CO2 from escaping and leaving 
the soda flat. Thus it must possess an additional property known as a gas barrier 
property – the resistance of the material to permeation by a gaseous species. It is 
thanks to the incredibly diverse population of polymers that one exists to meet 
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these requirements, namely polyethylene terephthalate (PET), the stiff, transparent 
plastic now used ubiquitously in soft drink containers around the world.  
 Hitherto gas barrier properties have been largely the domain of packaging 
specialists and vacuum technologist with little regard given to them by tissue 
engineers who have almost by default treated the structural polymer portion of 
their grafts as impermeable and largely passive. However, just as in the example of 
the pop bottle, by looking to the origins of polymers and appreciating the breadth of 
their properties beyond the rudimentary mechanical properties, it is possible to 
engineer new and exciting functionality into what was once just structural 
scaffolding. It is from this perspective and motivation that we investigate the 
physics of gas transport within polymer systems with the aim of developing an 
oxygen delivery strategy for tissue engineering scaffolds. 
 
Polymer Gas Barriers 
 We know from everyday experience that gases can permeate most solids. 
This is the reason a balloon will eventually deflate and why a pump is constantly 
needed to maintain a vacuum chamber. The degree to which gases permeate a solid 
depends on a number of factors (temperature, humidity, type of gas, pressure, and 
so forth) and can range over many orders of magnitudes, but the physical processes 
involved are common across materials, namely dissolution and diffusion. 
 The process of a gas entering a solid is known as dissolution and is governed 
by Henry’s Law51,52:  
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( II-1 ) 
  
 Where c is the concentration of gas within the solid, s is the solubility or amount of 
gas dissolved in the solid at STP, P is the pressure of the gas, and n depends on the 
material but is commonly 1 for non-metals. Thus it can be appreciated that the 
equilibrium amount of gas dissolved in a solid is proportional to the pressure of the 
gas in the environment around it. 
 At steady state, the movement of gas within the solid follows Fick’s Law of 
diffusion53:  




( II-2 ) 
  




represents the concentration gradient of gas within the solid. The diffusion 
coefficient is considered independent of the concentration of gas in most 
applications. 
 Combining Fick’s Law and Henry’s Law, the permeation of gas through a 
membrane can be modeled as in Figure II-1. Consider that each side of the 
membrane has pressure P1 and P2, respectively. Then by Henry’s Law we expect the 
concentration of gas at each side to be    
  and    
 , respectively. Now, assuming 
steady state, the concentration gradient across the membrane of thickness d will be: 
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 This equation is often sufficient for calculations involving the transport of 
gases into or out of packaging, as is commonly done for food or drug preservation. 
Of note from the equation are the limited variables that can be manipulated from a 
design perspective to modulate the flow of gas, specifically the thickness of the 
barrier and the barrier material of which   is an intrinsic property, as the pressure 
difference is typically prescribed by the application (i.e. ambient to vacuum). From a 
practical perspective, the thickness of a barrier cannot be greatly varied, likely less 
than 3 orders of magnitude for most commercial applications. However, it turns out 
that the permeation constant σ varies tremendously across different polymers, up to 
8 orders of magnitude. This provides the engineer with a means of making large 
steps in barrier properties by selecting different polymers and then fine tuning the 
properties by varying the thickness of the barrier. A list of commonly utilized 
polymers and their associated oxygen permeation properties is presented in Table 1 
from Kuraray Corp56 to give an idea of the magnitudes and range: 
Table 1: Table of oxygen permeability values of commonly used packaging materials. (*P) indicated 
the permeability of the films in units of cm3.20um/m2.day.atm at a temperature of T in Kelvin (K=273+°C). 
Reproduced from Kuraray EVAL EVOH Resins Brochure56. The permeability of a polymer is a highly 
temperature dependent property, roughly doubling with a 10°C increase in temperature. 
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Outgassing of a polymer slab 
 The fact that polymers can dissolve a significant amount of gas is not readily 
apparent from everyday experience, largely because the polymers are in 
equilibrium with the air and so the consequences are not readily observed. One 
tractable example however is the “new car” smell one detects in a recently 
manufactured automobile. This smell arises from gases and solvents trapped within 
the various polymers used to manufacture the car, seats, carpets, gradually diffusing 
out of the polymer and being released into the cabin air. This phenomena is called 
outgassing and occurs when a gas containing polymer is placed in an atmosphere 
without an equilibrium amount of gas. In most circumstances, outgassing is 
something to be avoided as it can increase the time required to pump down a 
vacuum chamber, introduce an unpleasant smell, or otherwise add a contaminant 
into a sensitive system. However, in the case of biomedical engineering the ability of 
polymers to dissolve and gradually release oxygen into the surrounding 
environment would be a major advantage. Thus we investigate the phenomena 
governing outgassing from a polymer slab. 
 The description of outgassing is really just the non-steady state (transient) 
description of the system used to develop the gas barrier equations and thus the two 
are intimately related. Consider an infinite polymer slab of thickness 2d, centered at 
the origin, with a coefficient of diffusion D. Assuming the slab is in equilibrium with 
a gas, by Henry’s Law we know that the initial concentration of gas within the 
polymer is C0 = sP. If the slab is then placed in an environment so that the surface 
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concentration of gas is held at C1, diffusion of the gas out of surfaces of the polymer 
will occur according to Fick’s 2nd Law, resulting in a the concentration profile57: 
 
       
     




     
    
    
            
   
     




   
 
( II-6 ) 
 
To calculate the amount of gas being delivered from a surface at any time, according 
to Fick’s 1st Law of diffusion, one need only calculate the concentration gradient at 
the surface and multiply by the coefficient of diffusion:  
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( II-10 ) 
Thus the outgassing from the face of each slab is described by the governing 
equation53: 
     
         
 
     
            
   
 
 
   
 
( II-11 ) 
 
The outgassing of a hyperbarically loaded polymer slab follows an exponential 
release with a time constant of: 
             
   
   
 
( II-12 ) 
  
The initial phase of the release exhibits a sort of burst due to the contribution of the 
rapid exponential terms, but these quickly dissipate leaving a release profile 
dominated by the first exponential term. From the time constant, it can be observed 
that the period of outgassing is proportional to the square of the slab thickness and 
inversely proportional to the rate of diffusion. Thus, thicker slabs exhibit 
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considerably longer periods of outgassing compared to thinner slabs, and thickness 
becomes a means of tuning the period of outgassing. 
 
Temperature Dependence of Permeation 
 The permeability of a polymer,  , depends strongly on temperature. This is 
largely expected given that       and both diffusion and solubility have 
temperature dependences, albeit exhibiting opposite trends.  
 For a gas to dissolve into a polymer two things must occur: 1) it must 
condense onto the polymer and 2) a molecular gaps large enough for the gas 
molecule must be created58. The partial molar enthalpy of sorption is thus 
represented by58,59:  
                     
( II-13 ) 
 
For condensable gases the condensation term is dominant and negative, thus 
resulting in decreased solubility of gases at elevated temperatures58. This is 
highlighted in the van’t Hoff equation58,60: 
             
   
  
  
( II-14 ) 
 
 For diffusion, the opposite trend is observed with rates increasing with 
temperature. This is because the movement of gas molecules through the polymer 
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network is a thermally activated process51. The relationship can be expressed in the 
form of the Arrhenius equation with ED the activation energy of diffusion52: 




( II-15 ) 
  
Compared to solubility, diffusion has a much greater temperature dependence and 
thus is the dominant term in the activation energy of permeation (Eσ = ED + HS), 
leading to the positive relationship between permeability and temperature51: 




( II-16 ) 
This trend is generally true, although there can be exceptions around glass 
transition points. 
 The temperature dependence of permeability is important from a gas barrier 
perspective as relatively small changes in temperature can result in dramatic 
changes in permeability, as highlighted in Table 1. For polymers, the value of Eσ is 
commonly within the range of 1,000-10,000K 56, which means on average for a 
temperature increase of 10°C , around room temperature, one can expect the 
permeability of the polymer to roughly double. Conversely, for a temperature 
decrease of 10°C one would expect the permeability to decrease by half. Thus to 
increase or decrease the permeability by a factor of 1,000x it is only necessary to 
change the temperature by 100°C. This attribute can be harnessed for biomedical 
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applications and will be discussed in more detail later. 
 
Outgassing of a hollow polymeric shell 
 Perfluorocarbon emulsions have been studied as a means of oxygenating 
blood and more recently as a means of delivering oxygen within a tissue engineered 
graft. While the capacity for perfluorocarbons to dissolve oxygen is impressive for a 
liquid (~50%V/V), their preparation as surfactant stabilized emulsions means that 
oxygen gas initially stored within the perfluorocarbon droplet rapidly diffuses out to 
equilibrate with the surrounding environment (useful for a circulating therapeutic 
that can be recharged each time it passes through the lungs, but useless as a 
reservoir for oxygen in a static application such as a tissue engineered scaffold). The 
ability to prolong the release of oxygen from perfluorocarbon droplets would allow 
significantly increase their utility within tissue engineering. To do so, would require 
the introduction of a gas barrier around the droplet to slow the release of gas and 
this motivates the study of gas delivery from a hollow polymeric shell. 
 Consider the geometry of the system: a sphere of radius r, with shell 
thickness d, which is composed of a polymer with gas permeability σ and is filled 
with gas at pressure P as in Figure II-2. 
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Within the system there is high pressure of gas within the core and a low pressure 
outside, separated by a relatively thin polymeric membrane.  From the investigation 
of gas permeation earlier, it is established that gas will permeate through at a rate 
of: 
   
       
 
 
( II-19 ) 
 
Due to the spherical geometry of the system, and the fact that the thickness of the 
polymeric membrane is thin with respect to the radius  
 
 
   , the area available 
for permeation is: 
       
( II-20 ) 
 
The equations for the change in gas    are interdependent through the pressure 
term. Thus by substituting one into the other, it is possible to understand the 




       
 
 
( II-21 ) 
 
The equations could be solved at this point, however, a simplifying assumption can 
be made with respect to pressure. It can be approximated that the driving 
pressure               because compared to the high pressure gas within 
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the core, the partial pressure of gas outside is approximately zero, especially in an in 
vitro or in vivo setting. This assumption does not affect the kinetics of the outgassing. 
 
   
         
   
 
( II-22 ) 
 
Substituting in for the known volume            and area: 
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Simplifying: 
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Results in the governing equation for outgassing from a hollow polymeric shell: 
 
            
  
 
           
   
      
 
( II-28 ) 
 
Thus theory predicts an exponential release profile, which intuitively makes sense 
because permeation of gas out of the core is proportional to pressure, which in turn 
is proportional to the amount of gas within the core. The time constant of release   
is also quite intuitive and informative. The time for release increases proportionally 
with the thickness of the shell and inversely with the permeability of the polymer. It 
also increases proportionally with the radius of the shell, which makes sense as 
smaller spheres have a higher ratio of surface area to volume and thus provide 
relatively more opportunity for permeation. 
 The rate of gas delivery or loss from the polymeric shell can be calculated by 
looking at the instantaneous change in the pressure equation: 
       
  
 




( II-29 ) 
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Or in terms of the molar delivery of gas: 
 
       
   
   










( II-30 ) 
 
The above equations consider a single polymeric shell; however, if the outgassing 
from a collection of polymeric shells is desired then one must simply multiply by the 
volumetric density (polymeric shells / volume): 
 
        
  
 




( II-31 ) 
 
Substituting in all the parameters that can be tuned or selected produces the 
governing equation for the volumetric gas delivery from a dispersion of polymeric 
shells: 
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For equilibrium, the force of pressure acting on the cross-sectional area must be 
balanced by tensile stresses in the wall. Thus: 
 
       
( II-34 ) 
 
               
( II-35 ) 
 
         
   
 
 
( II-36 ) 
 
As an example calculation, reasonable values of tensile strength for polymers is 10-
100MPa61 and the polymeric shell typically has a radius of 50um and a thickness of 
1um, so Prupture ≈ 2MPa ≈ 20atm. 
Analogously, for a polymeric closed-cell foam with an expansion ratio of 2: 
          
        
     
    
( II-37 ) 
 One can expect a rupture pressure of 10-100MPa ≈ 100-1000atm. 
 
Conception of Microtanks and Microtank-loaded Scaffolds 
 Upon considering the outgassing equations for polymeric slabs and thin-
walled shells as well as the corresponding mechanical limitations, it is possible to 
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conceive of means to utilize these properties to deliver oxygen to cells within tissue 
engineered scaffolds (and numerous other applications as well). 
 The simplest conceptual implementation is to use microscopic polymeric 
shells with sufficient mechanical strength and oxygen barrier properties to store 
hyperbaric oxygen gas and gradually deliver this gas to the surrounding 
environment to nurture cells. By analogy to the scuba tanks used to maintain divers 
under water, such polymeric shells have been termed MicroTanks or microtanks. 
Microtanks are capable of providing sustained oxygen delivery over an extended 
period of time. These hollow microspheres engineered from polymeric biomaterials 
can be hyperbarically loaded with oxygen. The intrinsic permeability of the polymer, 
which forms the surrounding shell, regulates the outward diffusion of oxygen along 
the pressure differential into the surrounding environment.  By varying the 
composition of the polymer, the thickness of the shell, the diameter, or the pressures 
to which the microtanks are loaded, it is possible to finely tune the rate and duration 
of oxygen delivery to the surroundings from several hours up to two weeks.   
 Within the subset of scaffolds designed for orthopedic applications, there is a 
commonly a structural phase made out of a relatively stiff, robust polymer and a 
hydrogel phase made up of growth factors, ECM proteins, and nutrients. By forming 
the structural phases out of a polymer with sufficiently low oxygen permeability and 
incorporating in microtanks, it would be possible to add oxygen functionality to an 
otherwise inert component. Experimental validation of this approach follows in 
Chapter III. 
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Outgassing from Composites of Microtanks Suspended in Bulk Polymer  
 In the case where a syntactic foam has been created by combining 
microtanks within a bulk polymer phase, the outgassing kinetics vary according to 
the relative contributions of the outgassing phenomena. One must consider that in 
such a system, oxygen must permeate 1) from the core of the microtank through the 
shell into the bulk polymer and 2) through the bulk polymer out to the scaffold-
hydrogel interface. In the case where the outgassing from the microtanks is very 
slow compared to outgassing from the bulk phase (e.g. very thin slabs), the kinetics 
are determined by the microtanks. Conversely, if the outgassing from the slab is 
very slow compared to the microtanks, then the kinetics are governed by the slab. If 
the kinetics of outgassing are comparable between the two stages, then the overall 
kinetics are approximately the sum of the individual kinetics. Generally speaking, 
outgassing of a composite scaffold occurs as: 
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CHAPTER III:  
 
Oxygen Delivery from Hyperbarically Loaded MicroTanks Extends 
Cell Viability in Hypoxic Environments 
 
 
Manuscript for Publication 
 The following chapter is written as a manuscript for submission to an 
academic journal. It covers the empirical data collected to validate the outgassing 
theory described in Chapter II as well as in vitro data to validate the therapeutic 
effect of oxygen delivery in hypoxic environments. 
 
Hyperbaric Chamber Apparatus  
 The hyperbaric chamber referred to within the manuscript was designed 
using thick-walled pressure vessel analysis, confirmed by FEM modeling in COMSOL, 
and manufactured in the BME Machine Shop by Jay Burns. The chamber is rated for 
operation up to 100atm and has been designed for use with pure oxygen. It includes 
a quick-connect fitting for connection to the high pressure oxygen tank, a bleed 
valve to return the chamber to atmospheric pressure, a pressure relief valve to vent 
gas in the case of over-pressurization, and a pressure gauge to monitor chamber 
pressure. The feed line from the high-pressure oxygen regulator is terminated with 
a one-way/check valve to prevent blowback into the main tank. The chamber is seen 
here in Figure III-1.  
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INTRODUCTION 
  Tissue engineered bone, muscle, liver, fat, and blood vessels have all been 
successfully demonstrated in small animal models. These successes are a bellwether 
of the promise of regenerative medicine to revolutionize healthcare by providing 
patient-specific grafts to replace damaged or failing tissue. These reports have 
helped establish the underlying biology of tissue formation and provided an 
encouraging proof-of-concept; however, they often overlook the challenges1–4 
associated with scaling the grafts from the mm3 domain of mice and rats to the cm3 
domain of humans. 
 Within small grafts the process of diffusion alone can accommodate the 
transport of nutrients, oxygen, and waste, where as in larger, so-called diffusion-
limited grafts, convection is required to meet metabolic needs. Unfortunately, 
convection requires functional vascular networks5,6 and these can take several days 
to weeks to form. During this period, cellular metabolic demand exceeds supply 
leading to nutrient deficiency and hypoxia1,7,8, which can lead to cell death and graft 
failure if persistent. 
 Diffusion limitations apply to all metabolic molecules and can be estimated 
by comparing rates of delivery and/or generation to rates of consumption, as is 
captured in the Thiele modulus9 (1D case):     
         
   
, with scaffold thickness 
h, cell density      , cellular oxygen uptake rate     , Michaelis constant  , and 
oxygen diffusion D. A large Thiele modulus indicates diffusion limitations and hence 
the presence of gradients. When considering cell metabolism both the deficit of 
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nutrients as well as the accumulation of waste products can be problematic10,11. 
However, in examining the prototypic equation of glucose metabolism it becomes 
apparent that oxygen is of special importance3,6. If oxygen is present, cellular 
respiration is able produce 30 ATP per glucose molecule and the relatively fast 
diffusing CO2 waste product where as if oxygen is not available anaerobic glycolysis 
is only able to net 2 ATP plus the relatively slow diffusing lactic acid waste 
product7,12. The fact that oxygen directly impacts the diffusion limitations of glucose 
and waste products underscores the two-fold dangers of hypoxia within tissue-
engineered grafts. 
 Given the deleterious consequences of hypoxia within diffusion-limited 
grafts, a number of approaches have been investigated to augment oxygen supply 
within nascent grafts to maintain cell viability during the period of vascularization. 
These have included: hyperbaric oxygen therapy where the patient and/or graft is 
placed in an oxygen enriched environment to enhance the oxygen content dissolved 
in the blood and interstitial fluid24,27–29, perfluorocarbon emulsions which utilize the 
high oxygen solubility properties of these chemicals to enhance diffusion rates2,30–33, 
and various peroxide compounds which generate oxygen during a decomposition 
reaction34–36. While each of these approaches has highlighted the benefits of oxygen 
augmentation, they unfortunately each suffer from limitations in terms safety 
and/or efficacy that have prevented their widespread adoption. Thus there remains 
a significant need for approaches that can deliver oxygen within grafts over 
extended periods of time. 
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 In this paper, we describe a novel oxygen delivery strategy, which avoids 
many of the drawbacks of previous approaches. The approach centers around a 
microscopic hollow polymeric balloon that can be hyperbarically loaded with 
oxygen and subsequently release the gas back into the surrounding environment to 
nurture cells over an extended period of time. As the cellular analogue to a scuba 
tank we have termed these oxygen carriers: MicroTanks and they are diagramed in 
Figure III-2. The polymeric shell of the microtank provides dual functions: 
mechanical confinement of the pressurized oxygen and a gas barrier to control the 
diffusion of oxygen out of the hollow core. With interest in bone tissue engineering, 
the microtanks were combined into the structural polycaprolactone phase of 
scaffolds. Thus in our system oxygen diffuses out of the microtanks, through the 
bulk PCL phase, and ultimately into the hydrogel phase where it is consumed by 
cells. The aim of this paper is to lay the theoretical framework for the microtank 
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MATERIALS & METHODS  
Fabrication of Microtank Containing Scaffolds 
 Scaffolds containing microtanks were fabricated by melting polycaprolactone 
(InstaMorph, USA) at 100°C and combining with commercially available 
microballoons E030 (Henkel, CT, USA). The mixture was then cast into sheets of 
varying thicknesses and subsequently formed into disks using a hand punch (14mm 
diameter). 
 The final concentration of microtanks by volume was calculated by casting a 
200um sheet of the mixture, imaging using a bright field microscope, and using 
ImageJ to quantify the volume of microtanks within the known volume of the 
imaged material.  
 
Loading of Microtank Containing Disks 
 Disks and scaffolds were loaded with oxygen in a custom built hyperbaric 
chamber. The chamber was loaded to pressures of 10-20atm with pure oxygen for a 
periods equal to at least 3 times the periods of release for the disks. In some 
instance, disks were removed from the chamber following loading to prerelease for 
a given period before starting an experiment to provide different levels of oxygen 
delivery. 
 
Quantitative Measurement of Oxygen Release Profiles 
 A Seahorse XFe24 Extracellular Flux Analyzer (Seahorse Bioscience, USA) 
was used in conjunction with islet plates to provide quantitative measurement of 
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oxygen release from the scaffold material. Briefly, the polycarbonate XF24 Islet 
Capture rings were filled with the scaffolds material, hyperbarically loaded with 
oxygen, and then placed within the 24-well microplate. The disks were covered with 
625uL of XF solution and the delivered oxygen was allowed to diffuse to 
atmosphere. Individual oxygen probes monitored the oxygen levels within the 
solution at increments of 20minutes for the first 6 hours and every 30minutes 
thereafter.  Changes in oxygen levels over time were used to produce an oxygen 
delivery plot. 
 
Visualization and Semi-quantitative Measurement of Oxygen Release 
 A colorimetric assay for oxygen release from scaffolds was developed to 
provide visual corroboration to oxygen probe-based methods. A solution of oxygen 
sensitive resazurin dye (3mL of 0.1%), sodium hydroxide (1M), and glucose 
(0.133M) was prepared that turns pink in the presence of oxygen and clear in the 
absence of oxygen. This occurs by the oxidation of the dye through the conversion of 
glucose to gluconic acid. As the oxygen is consumed in the reaction, this solution 
enables the observation of quasi-steady state oxygen delivery rates from scaffolds, 
where the intensity and thickness of the pink band emanating from the scaffold 
surface is proportional to the flux of oxygen. 
 To measure the flux of oxygen, 14mm diameter disks of various thicknesses 
composed of PCL and microtanks were cast, loaded with oxygen, and mounted 
vertically to a weighted support structure so their profile could be observed. The 
disks were placed in a glass enclosure, submerged in fresh resazurin solution, and 
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allowed to reach quasi-steady state (~5min). A digital camera was used to take 
images of the disk profile and resazurin bands. 
 The widths of the bands are quantified using a custom Matlab program. 
Briefly, the program aligns the disk to 90 degrees, crops the central 1/3 of the disk, 
extracts the green channel for maximum contrast, plots the average intensity (gray 
value) of the image from which the widths of the resazurin band and the disk are 
extracted. In the green channel the resazurin band shows up as a dark region in 
contrast to the white disk and background, producing a valley shape in the profile 
plot. For consistency, the width of the band is taken as the width at half-maximum of 
this valley. For each image, the pixel width of the bands from left and right faces are 
measured, averaged, and normalized by the pixel width of the disk to compensate 
for any variations in zoom of the image. 
 
Cell Culture and Media Conditions 
 
Timecourse 
 Human ASCs (Passage 3-5) were combined into fibrin gels (8mg/mL bovine 
fibrinogen, 2U/mL thrombin, in PBS) and cast into 100uL gels in a polycarbonate 
4mm inner diameter mold at a cellular concentration of 2,500 cells/uL. The 
polycarbonate disks were positioned on top of the PCL and microtank disk samples 
(12mm diameter x 4mm thick), which were glued to the bottom of 12-well plates. 
Three groups of identical microtank filled PCL disks were used (n=4): Neg, in which 
the disks were purged with nitrogen, Pos, in which the disks were equilibrated in 
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atmosphere, and uTank, in which the disks were loaded in 100% O2 at 15atm and 
allowed to pre-release for 24hrs before cell seeding. 
 Cells were fed with 2mL of expansion medium (89mL Low Glucose DMEM, 
1mL FBS, 1mL P/S, 20uL FGF) and then placed in anoxic chambers, which were 
purged for 15min with anoxic gas mixture (5% CO2 + 95% N2) then sealed closed. 
The chambers contained oxygen-absorbing packs to quench any released oxygen. 
Chambers were incubated at 37°C and contained a water reservoir to maintain 
humidity. Pos were cultured under normoxia (21% O2 + 5% CO2 + 74% N2). Samples 
were removed at Day 0, Day 2, Day 4, Day 6, and Day 8 time points for analysis. 
 
Oxygen Sensitivity 
 Human ASCs and HUVECs were combined (ratio of 2.5:1) at 2,500 cells/uL 
into fibrin gels and cultured on disks similarly to the timecourse study with the 
following groups (n=4):  Neg, in which the disks were purged with nitrogen, Pos, in 
which the disks were equilibrated in atmosphere, and uTank (High, Med, Low), in 
which the disks were loaded in 100% O2 at 15atm and allowed to pre-release for 30, 
54, and 78hrs, respectively, before cell seeding. Cells were fed with 2mL of 
expansion medium (89mL Low Glucose DMEM, 1mL FBS, 1mL P/S, 20uL FGF) and 
then placed in anoxic chambers, which were purged for 15min with anoxic gas 
mixture (5% CO2 + 95% N2) then sealed closed. The chambers contained oxygen-
absorbing packs to quench any released oxygen. Chambers were incubated at 37°C 
and contained a water reservoir to maintain humidity. Samples were removed at 
Day 6 for analysis. 
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Vascular Assembly 
  Human ASCs and HUVECs were combined at 2,500 cells/uL each into 
fibrin gels and cultured on disks similarly to the timecourse study with the following 
groups (n=4):  Neg, in which the disks were purged with nitrogen, Pos, in which the 
disks were equilibrated in atmosphere, and MicroTank, in which the disks were 
loaded in 100% O2 at 15atm and allowed to pre-release for 30hrs before cell 
seeding. Cells were fed with 5mL of endothelial cell media and then placed in anoxic 
chambers, which were purged for 15min with anoxic gas mixture (5% CO2 + 95% 
N2) then sealed closed. The chambers contained oxygen-absorbing packs to quench 
any released oxygen. Chambers were incubated at 37°C and contained a water 
reservoir to maintain humidity. Samples were removed at Day 4 for L/D analysis. 
 
PicoGreen DNA Assay 
 The PicoGreen assay was carried out according to the manufacturer’s 
instructions. Gels were transferred into 600uL of TEX + Proteinase K and frozen at -
20°C. Samples were subsequently heated at 55°C overnight to digest proteins and 
lyse cells. The samples were combined with PicoGreen reagent (20uL sample + 80uL 
TEX + 100uL PicoGreen) and transferred (200uL) into opaque 96-well plate along 
with DNA standards. Fluorescence was measured at 485/528 using a plate reader. 
 
Alamar Blue Assay 
 A solution of 0.001% resazurin in expansion media was prepared fresh and 
added at 2mL/well to a 24-well plate. Gels were transferred individually into the 
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wells and allowed to incubate for 2hrs at 37°C in the incubator. 200uL samples of 
the solution were placed in opaque 96-well plates and measured using fluorescence 
spectrometry at 540/590nm using a plate reader.  
 
Predictions of Cellular Oxygen Uptake Rates 
 Cellular uptake rates for human endothelial and adipose derived stem cells 
were obtained from the literature62,63. The metabolic demand of cells was estimated 
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RESULTS 
Governing Equations of Oxygen Delivery from Microtank Containing Scaffolds 
 
 Upon hyperbaric loading, oxygen enters the microtanks according to the 
ideal gas law   
  
  
 and dissolves in the bulk PCL according to Henry’s law 
         , where Φ is the volume fraction of microtanks, P is the loading 
pressure, R is the ideal gas constant, T is temperature, and S is the solubility 
constant of oxygen in polymer. Thus at equilibrium the concentration of oxygen is 
proportional to the loading pressure and the volume fraction of microtanks as: 
    
 
  
         . 
 
 In order for gas to be delivered from the scaffolds it must diffuse from the 
microtanks through the PCL to the scaffold surface. While the kinetics of the delivery 
will vary according to geometry, for the simple case of outgassing from a slab the 
delivery of gas from the surface goes as: 
     
    
 
     
           
   
       ,                   
   
   
. 
 
 In addition to the diffusion of gas through the bulk polymer phase, oxygen 
must also permeate through the thin polymeric shell of the microtanks. The rate of 
transport (  ) of a gas through a thin membrane is proportional to the pressure drop 
(  ) across the membrane, the area (A) of the membrane, and the permeability ( ) 
of the membrane to the gas, which is the product of the solubility diffusion of the gas 
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within the polymer          , while inversely proportional to the thickness (d) 
of the membrane:    
       
 
. Thus for a microtank of radius (r) loaded to a pressure 
(P0) the oxygen delivery rate follows the exponential form: 
    
          
 
    
  
   
      
                     
   
      
 
 
 Thus the oxygen delivery from hyperbarically loaded microtank containing 
scaffolds exhibits an exponential delivery profile combined of components from the 
bulk phase and the microtank phase. As an approximation the time constant of 
oxygen delivery is the sum of the time constants of the constitutive phenomena: 
                               . 
 
 To validate the theory governing oxygen delivery from microtank containing 
scaffolds, PCL disks with and without microtanks were fabricated, loaded with 
oxygen, and then the oxygen delivery rate was monitored using a Seahorse XFe24 
Extracellular Flux Analyzer. The profiles, illustrated in Figure III-3a, were fitted with 
the theoretical equation to extract time constants and integrated to calculate the 
total oxygen content within the disks, summarized in Figure III-3b. The microtank 
loaded disk is observed to have a significantly higher time constant than the disk 
without, suggesting the microtanks contribute significantly to slowing the release of 
gas from the disks. Additionally, the total oxygen content in the microtank-loaded 
disks is roughly 3x that of the disk alone, demonstrating the ability of microtanks to 
significantly increase the capacity of hyperbarically loaded materials.  
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Colorimetric Assay of Oxygen Delivery 
 In scaling to larger scaffolds, the Seahorse XFe24 Extracellular Flux Analyzer 
is no longer suitable for monitoring oxygen release so we developed a 
semiquantitive colorimetric assay to allow for visual monitoring of oxygen delivery 
as well as extraction of time constants of release. The assay utilizes the color 
changing properties of resazurin dye in the presence of oxygen to spatially indicate 
oxygen delivery. By imaging scaffolds successively over time and monitoring the 
intensity and widths of the resazurin bands emanating from the scaffolds it is 
possible to further characterize the oxygen delivery temporally. Figure III-4 
highlights this method. Again, the release profile is consistent with the theory.  
 
Tuning Oxygen Delivery Profiles 
 
 We sought to further characterize the oxygen delivery in larger scaffolds as a 
function of scaffolds thickness. As shown in Figure III-5, disks with thicknesses of 
1mm, 2mm, and 4mm were fabricated, loaded with oxygen, and then monitored by 
the resazurin assay for the kinetics of oxygen delivery. The release profile obtained 
was fitted with the theoretical release profile to extract a time constant of release. It 
is observed that thicker disks exhibit significantly longer periods of release. This 
trend is consistent with the theory; however, the relationship is expected to be 2nd 
order where as empirically it is observed to be between 1st and 2nd order. 
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 Additionally, the relationship between microtank concentration and oxygen 
delivery was investigated. Briefly, PCL disks containing 0%, 1.4%, or 7% V/V 
microtanks were fabricated, loaded with oxygen, and monitored by resazurin assay 
for oxygen release. The relative flux of oxygen from the disks was compared as is 
summarized in Figure III-6, suggesting that oxygen delivery can be tuned by 
increasing the concentration of microtanks within the scaffold.  
 
Scaffold Storage 
 From the theory, it is observed that the time constant of oxygen delivery is 
inversely proportional to the rate of diffusion within the polymer. It is well 
established that diffusion is a temperature dependent property; however, as 
temperature increases the solubility of gases within the polymer decreases. The net 
effect of these competing phenomena is best captured in the gas permeability 
         , which has the form            
   
  
 . For polymers EP/R is 
commonly on the order of 5×103 K (EVOH manual), so around room temperature a 
decrease of 10°C will halve the permeability. We therefore sought to investigate if 
cooling could provide a facile means of storing and shipping loaded scaffolds prior 
to implantation. 
 Disks of PCL containing microtanks were loaded with oxygen and then stored 
for 1 week at ambient pressure at 20°C, -20°C, or -80°C, or at loading pressure in the 
hyperbaric chamber. Following the week of storage, the magnitude of oxygen 
delivery from the disks was compared using the resazurin assay. The results of this 
experiment are summarized in Figure III-7 and reveal that disks stored at -20°C and 
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-80°C have maintained equivalent oxygen content to freshly loaded disks (i.e. those 
stored within the hyperbaric chamber). In contrast, disks stored at 20°C has 
significantly less oxygen content than all groups. While not statistically significant, 
the disks stored at -80°C maintained slightly higher oxygen content than those at -
20°C.  
  
Time course of Therapeutic Effect 
 
 Having characterized the delivery of oxygen from microtank containing 
disks, the therapeutic potential to extend cell viability in hypoxic environments was 
assessed by monitoring cellular metabolism over time with and without microtank-
loaded scaffolds. Briefly, an Alamar Blue assay was used to measure the metabolism 
of ASCs cultured on PCL disks in 100uL 3D fibrin gels under anoxic conditions out to 
8 days. The 4mm disks from the characterization experiments were used, as they 
possessed the largest time constant. Anoxic culture conditions (0% O2, 5% CO2, 95% 
N2) were used to simulate the worst-case scenario within diffusion limited grafts. 
Positive controls groups were cultured under “normoxic” conditions (21% O2, 5% 
CO2, 74% N2) to provide a benchmark. 
 At each time point, the relative metabolism of the cells normalized to the 
positive control was measured and the results are presented in Figure III-8. It can be 
observed that the metabolism of the negative control group, which contained 
scaffolds without microtanks, drops steadily under anoxia. In contrast, the group 
containing microtanks maintains appreciable metabolism out to Day 4 before 
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beginning to drop off at Day 6. This suggests that the oxygen delivery from the 
microtank loaded scaffolds is able to provide a therapeutic benefit to ASCs under 
anoxic conditions. 
 
Sensitivity to Oxygen Delivery vs Cellular Demand 
 
 Having demonstrated that cell metabolism under anoxic conditions can be 
extended using microtank loaded scaffolds, we sought to investigate how the 
amount of oxygen delivery affected cell growth. Three different amounts of oxygen 
delivery were selected, based upon predicted cellular demand, to be higher, lower, 
or equal to demand. Figure III-9a illustrates the ratio of 
             
               
 over time 
based on the measured oxygen uptake rate for ASCs from the literature and the 
previously measured oxygen delivery rate for the disks over time. 
 Cell growth was determined by measuring DNA content at Day 6, the 
previously determined therapeutic limit for these scaffolds, by PicroGreen Assay. A 
similar experimental setup was utilized. The results of this experiment are 
summarized in Figure III-9b and several notable trends are observed. Firstly, all 
microtank containing scaffolds performed significantly better than the negative 
control. Secondly, the cell growth in the microtank groups correlates with the 
amount of oxygen delivered, with groups receiving more oxygen exhibiting more 
growth. Thirdly, cell growth in the microtank groups is comparable to the positive 
control.  
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Oxygen Delivery Enhances Vessel Formation 
 
 Co-cultures of ASC:HUVECs demonstrated expansion and elongation after 4 
days in fibrin gels. Live/dead confocal imaging of the gels, Figure III-10A, 
demonstrates a higher proportion of live cells within the Positive and MicroTank 
groups compared to the Negative group. Quantification of the ratio of live/dead 
cells, Figure III-10B, is similar between the Positive and Microtank groups, where as 
the Negative group displays significantly less viable cells than the MicroTank group, 
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DISCUSSION 
 The use of oxygen outgassing from hyperbarically loaded scaffolds to 
maintain cell viability under hypoxic conditions, in so far as we are aware, 
represents a completely novel therapeutic approach. The approach provides a 
number of advantages when compared to previously described oxygen delivery 
technologies. Firstly, there are no cytotoxic byproducts produced in contrast to 
peroxide-based approaches, which release reactive oxygen species intermediates, 
acid, and commonly Ca2+ stoichiometrically with each O2 molecule generated. 
Secondly, the system has a relatively high oxygen delivery capacity as compared to 
perfluorocarbon-doped scaffolds, which are only able to contain approximately 50% 
v/v O2 at 1 atm, allowing for sufficient oxygen for nearly a week and possibly longer. 
Thirdly, the approach is highly tunable and the oxygen delivery characteristics have 
been well established. 
 The aim of this paper was to present the governing principles, proof-of-
concept, and therapeutic benefit of the microtank approach. Therefore, there are a 
number of elements that need addressing before it could be considered as clinically 
viable, but we do not believe they undermine the long-term feasibility of the 
approach. Firstly, the use of polyacrylonitrile microballoons within the system is not 
appropriate for translation due to long-term biocompatibility concerns and toxic 
degradation products. However, these could be substituted for microballoons made 
of a more suitable polymer, such as a PLGA, and in fact we have begun working on 
developing biocompatible/bidegradeable microtanks with this in mind. Secondly, 
the use of PCL may not be appropriate for all applications; however, given its ease-
  55 
of-use and low melting point it allowed for the bench-top fabrication of scaffolds, 
obviating the need for expensive processing equipment necessary for other 
thermoplastics. Finally, the geometries and scaffold sizes used within this study 
have not been selected for a specific application, but could be formed into 
appropriate shapes using 3D printing, injection molding, thermoforming, etc. The 
scaffold thicknesses utilized were necessary to achieve biologically meaningful 
periods of oxygen release; means of addressing this limitation are subsequently 
discussed.  
 The loading and storage of microtank containing scaffolds presents a couple 
of logistical challenges. Firstly, with loading the time to equilibrium is approximately 
4-5 time constants; however, for scaffolds with periods of release of even 48 hours 
this can become time consuming. It is unlikely that such turn around times would be 
accepted in a medical setting. Fortunately, by loading the scaffolds at elevated 
temperatures, well below melting point, it should be possible to greatly reduce 
loading times by 1 to 4 orders of magnitude, i.e. down to hours and minutes. This 
will require a hyperbaric chamber designed for operation at elevated temperatures 
and safety considerations given the use of pressurized oxygen but is well within the 
realm of technical feasibility. The second challenge relates to the storage of oxygen-
loaded scaffolds. However, as we have demonstrated the cooling of scaffolds 
significantly enhances the shelf life and by theoretical estimates storage to outwards 
of 35 to 15,000 times the period of release are expected for -20°C and -80°C, 
respectively. These findings improve the translational potential of the microtank 
approach.  
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 While this work has primarily relied on the bulk PCL polymer phase of the 
scaffolds to control and extend the release of oxygen, it may be possible to engineer 
the microtanks themselves to provide the necessary oxygen barriers. In the current 
system, the time constant of release is directly related to the scaffold geometry. This 
places constraints on the possible geometries that can be formed while maintaining 
therapeutically meaningful periods of oxygen delivery. In contrast, if the microtanks 
themselves had the desired period of release then there would no longer be 
practical limitations on geometry beyond the dimensions of the microtanks. This 
would require the thin polymeric shell of the microtank to have a high oxygen 
barrier, such as that afforded by polyvinyl alcohol (PVA). The development of PVA 
microtanks is thus an ongoing aim of our laboratory.  
 Alternatively, it may be possible to utilize a bulk phase polymer with 
significantly lower diffusion rates of oxygen than PCL to increase the period of 
oxygen delivery out to 2-3 weeks without the need to utilize impractically thick 
segments of scaffolding. Dacron (a.k.a. polyethylene terephthalate) has 
approximately 1/10th the diffusion constant as PCL and therefore may be a suitable 
replacement. By utilizing a constant diameter filament/strut size, uniform oxygen 
delivery throughout a complex shaped scaffold could be accomplished through 3D 
printing methods. The results from this study compel us to work to extend the 
release profile of hyperbaric loaded microtank containing scaffolds to overcome the 
acknowledged limitations of PCL scaffolds, thus enhancing the overall therapeutic 
impact. 
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 An important finding of this study was that oxygen delivery could support 
vessel formation under anoxic conditions. This suggests that it may be possible to 
maintain cells in vivo long enough for functional vasculature to develop to nurture 
the graft. While these results provide proof of concept, additional studies will be 
required to evaluate the robustness of the vessel formation, optimize the cell 




 The outgassing of hyperbarically loaded materials has the potential to 
mitigate the negative effects of hypoxia within tissue-engineered grafts, especially 
where the graft contains a structural phase in addition to a hydrogel phase. The 
approach can add oxygen delivery functionality in a facile and predictable manner. 
The local delivery of oxygen may produce similar therapeutic benefits to hyperbaric 
oxygen therapy, without the need for systemic delivery and expensive and 
cumbersome chambers. Beyond tissue engineering the approach may hold promise 
to reduce infections, increase collagen deposition, and enhance healing, which 
would make it particularly attractive for use in medical fasteners such as screws, 
plates, and sutures. The diverse applications and implementations of the approach 








Figure III-2: Schematic of microtank loaded PCL scaffolds. Scaffolding material composed of PCL is 
embedded with microtanks to create a syntactic foam with distributed closed-cells. The microtanks contain 
a hollow core, which can be hyperbarically loaded with gaseous oxygen, surrounded by a polymeric shell 
composed of a structural, oxygen barrier layer to contain the pressurized oxygen. The pressure differential 
across the microtank shell drives the outward diffusion of oxygen through the shell and into the bulk PCL 
where it continues to diffuse out to the periphery of the scaffolding and into the media/hydrogel to nourish 
cells. The release of oxygen from microtank embedded scaffolds is regulated by the rate of permeation 
through the shell plus the rate of permeation through the bulk phase. 
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Figure III-3: Microtanks enhance oxygen delivery capacity and duration. (A) Oxygen delivery from 
hyperbarically loaded disks with microtanks (+uTanks) compared to without (-uTanks), fitted with 
theoretical delivery profile to extract time constants of delivery. (B) Total oxygen delivered was calculated 
by integrating the delivery curves while time constants of delivery were calculated from fit. 
 
 
Figure III-4: Resazurin assay provides colorimetric visualization and quantitation of oxygen delivery 
duration from microtank containing PCL disks. (A) Photograph of 2mm thick disks in resazurin 
solution indicating oxygen release (pink) over a period of 2 days. (B) Green channel of photographs (left) 
are used to quantify the thickness of the resazurin bands emanating from the disks by plotting the average 
horizontal profile of the image (green box) and extracting the band widths (red) and disk thickness (blue) at 
half maximum. (C) Plotting the thickness of the resazurin band over time (blue circles) and fitting with the 
theoretical oxygen delivery equation (red) allows for the extraction of the time constant of delivery. 
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Figure III-5: Time constant of oxygen delivery increases with polymer thickness. Stacked bar graphs 
illustrate the contribution of the microtank (blue) vs bulk phase (red) time constants to the total outgassing 
time constant. Microtank filled PCL disk with thicknesses of 1mm, 2mm, and 4mm (pictured below in 
resazurin solution) were monitored over 1 week to extract time constants of delivery (above). N=3. * 
indicates significant difference (P<0.05 by one-way ANOVA and Tukey’s HSD). 
 
 
Figure III-6: Amount of oxygen delivery increases with microtank concentration. Plot of relative 
amount of oxygen released at 1hr time point from PCL disks containing 0, 1.4, or 7% V/V microtanks, 
normalized to pure PCL disk. N=3. * indicates significant difference (P<0.05 by one-way ANOVA and 
Tukey’s HSD) between the 7% and the 0%, 1.4% groups. 
  61 
 
Figure III-7: Low temperatures enable storage of hyperbarically loaded scaffolds. Plot of relative 
amount of oxygen delivered at 1 hr time point from hyperbarically loaded PCL disks containing microtanks 
that were stored for 1 week in ambient pressure at 20°C, -20°C, or -80°C, normalized to disks stored under 
loading conditions in hyperbaric chamber. (N=2). * indicates significant difference (P<0.05 by one-way 
ANOVA and Tukey’s HSD) from all other groups. 
 
 
Figure III-8: Time course of ASC metabolism under anoxic conditions. Results of Alamar Blue assay 
of ASCs cultured in 3D fibrin gels on top of PCL disks containing oxygen loaded microtanks (uTanks), 
nitrogen purged microtanks (Neg), or ambient microtanks (Pos). uTank and Neg groups were cultured 
under anoxia (0% O2, 5% CO2, 95% N2) while the Pos group was cultured under normoxia (21% O2, 5% 
CO2, 74% N2). N=3. * indicates significant difference (P<0.05 by one-way ANOVA and Tukey’s HSD) 
between indicated pairs. 
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CHAPTER IV:  
 
Translational Efforts and Applications 
 
 
Development of standalone microtanks 
 From a translation perspective, it would be beneficial to formulate 
microtanks that possess the desired periods of release, biodegradable properties, 
and sufficient mechanical integrity to act as a stand-alone or additive component. 
The present implementation with microtanks embedded in PCL has potential utility 
within bone tissue engineering; however, the requirements of a structural phase 
limit the scope of application. The following will outline strategies and work done to 
extend the utility of the microtank approach for broader application. 
 
Double emulsion approaches to engineer standalone microtanks 
 Double emulsions are a commonly utilized approach for forming 
microspheres and microcapsules64. Briefly, an aqueous phase containing the active 
compound is emulsified into an organic solvent phase containing the encapsulating 
polymer to form the primary water in oil emulsion (W/O). The primary emulsion is 
subsequently emulsified into an aqueous phase containing a surfactant, creating a 
water in oil in water double emulsion (W/O/W). The organic solvent is then 
evaporated causing the polymer to condense around the active compound. Thus 
microscopic, mono- or multi-core particles are formed65. Obviously, the 
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complimentary (O/W/O) double emulsion can be made too.  Stir rates, evaporation 
rates, presence of surfactants, temperature, and viscosity can be varied to achieve 
different particle geometries. 
 Using a double emulsion approach, a strategy for forming biodegradeable, 
stand-alone microtanks was developed. The concept was to form a poly-lactic-
glycolic acid polymer shell encapsulating a polyvinyl alchohol aqueous core, and 
subsequently evaporate off the water thus depositing the polyvinyl alcohol as an 
interior shell/coating. The PLGA outer shell is used for two purposes: firstly, it acts 
as a vapor barrier to protect the humidity sensitive PVA interior shell, and secondly, 
it acts to control the rate of degradation as the hydrolysis of PLGA can be easily 
tuned by changing the ratio of PLA:PGA of the polymer (PLA degrades much more 
slowly than PGA). The PVA interior shell acts as the oxygen barrier, the thickness of 
which controls the period of release from the microtank. As PVA is water soluble, 
once the PLGA shell biodegrades within the body the PVA is able to dissolve and be 
cleared from the body. Both PLGA and PVA are generally recognized as safe (GRAS) 
by the FDA. 
 A solution of 10% PVA in water was prepared by adding 10g of PVA into 
100mL of water, bringing to a boil, and cooling to room temperature; Coomasie 
brilliant blue dye was added to better visualize the PVA phase. This acted as the first 
aqueous phase. A solution of 0.5% PVA was similarly prepared. This acted as the 
second aqueous phase. A solution of 0.5g PLGA was dissolved in 20mL of 
dichloromethane. This acted as the oil phase. 1mL of 10% PVA solution was 
emulsified in 20mL of the PLGA/dichloromethane phase by sonication at 10W for 
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30s. This emulsion was immediately poured into a 1000mL beaker containing 
500mL of 0.5% PVA being stirred at 500rpm. The dichloromethane was allowed to 
evaporate overnight. The resulting particles were collected and washed 3x under 
distilled water.  
Results: 
 Particles were imaged using bright field microscopy, shown in Figure 
IV-1A,B. Results indicated a mix of mono and multi-core particles with PLGA 
encapsulating a PVA aqueous core. Particle sizes ranged from 20-200um. 
Subsequently, particles were subject to drying under vacuum to drive off the water, 
shown in Figure IV-1C. The particles were found to be buoyant in water, indicating 
that they contained a hollow core. 
 To validate the formation of a PVA inner core, the PLGA outer core was 
dissolved away in dichloromethane. The resulting particles exhibited an 
approximately spherical geometry with visible lumen or hollow core as in Figure 
IV-1D-G. Buoyancy tests indicated that the particles were indeed hollow. These 
results suggest that the double emulsion approach is feasible for the formation of 
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microcapsules are formed in two subsequent steps, within microfluidic approaches 
the microcapsules form in a single step as concentric streams of fluid pinch off into 
droplets. Based on the spatial organization of the system, it can be appreciated that 
the analogous primary emulsion is formed by injection of the inner aqueous phase 
into the dichloromethane/PLGA middle phase, and the analogous secondary 
emulsion is formed by injection of this concentric stream into the second aqueous 
outer phase. By varying the respective flow rates it is possible to generate 
microcapsules with a range of shell thicknesses and core diameters67. Evaporation 
of the aqueous core can transform the microcapsule into a microtank. Such an 
approach can be scaled up by utilizing massively parallel systems68.  
 
 
Figure IV-2: Capillary microfluidic approach to core-shell particle formation. The inner phase is 
injected through a concentric needle into the middle phase. These concentric streams are subsequently 
encapsulated by the outer phase and break up into droplets with a core-shell morphology. Varying the 
respective flow rates can alter the particle geometry and relative proportions of the shell and core. 
Reproduced from Shum, H. C. et al., 200866. 
 
Interfacial polymerization approach, new chemistries, results 
 Interfacial polymerization is another approach commonly utilized in the 
formation of mono-core microcapsules, notably within the pesticides and 
pharmaceutical industry69. The approach relies on two complimentary monomers –  
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one monomer is soluble an aqueous phase and the other in an oil phase – which 
react with each other to form an insoluble polymer70 as in Figure IV-3A,B. The 
compound to be encapsulated is dissolved in the desired phase and then emulsified 
to form microdroplets. The reactive monomers will meet at the liquid interface 
surrounding the droplet and begin developing a membrane, thus encapsulating the 
droplet. The advantage of interfacial polymerization is that encapsulation occurs in 
a single step and all particles are perfectly mono-core.  
 Commonly utilized monomer pairs are71–73: polyamine (PEI/TDC, 
SMA/polyamines, polyamine/polyuria, PEI/SC/TC/HAD, polyamide/polystyrene), 
polyurethane (IPDI/propanetriol, PU/poly(ether urethane), poly(ortho 
ester)/polyester, polyepoxide (EGDE/HMDA/DETA), polysiloxane (OES/TEOHS), 
polythiourea (TDITC/OPD), photo-cross-linking polyuria (polymeric 
isocyanate/polyamine), polyuria (MDI/HMDA/HMDI/DETA/polyamine, 
TDI/amines, nylon 6,10).  
 With consideration for biocompatibility and biodegradation, a new pair of 
monomers was investigated utilizing urethane chemistry. A urethane is most 
commonly formed by the reaction of an isocyanate (R–N=C=O) and an alcohol (R’-
OH) to produce a urethane linkage (RNHCOOR’). Isocyanate can also react with itself 
in the presence of water to form a urea linkage (R-NH-CO-NH-R) and carbon dioxide 
gas. Polyurethane is thus formed by combining a di-/poly-isocyanate with a di-
/poly-ol. In this study, PVA was utilized as both the polyol and the compound to 
encapsulate while HDMI was utilized as the diisocyanate, Figure IV-3B. Previous 
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 Optimization of the polyurethane chemistry will need to be carried out to 
ensure the shell is mechanically rigid enough to support the subsequent evaporation 
of the aqueous core to coat the interior with a PVA shell. This may be accomplished 
by adding cross linkers to the aqueous phase such as glycerol to increase the rigidity 
of the polymer shell. 
 
Simplicity by thoughtful reduction – Outgassing of polymeric foams 
 The generation of standalone microtanks represents a significant 
undertaking. Therefore, it is worth considering if the microtank concept can be 
simplified even more while maintaining the desired periods of release and oxygen 
capacity. Perhaps the most reduced implementation of the concept would be to use 
outgassing from hyperbarically loaded materials as a source of oxygen delivery. It is 
well established from the literature that many polymers have an intrinsic solubility 
for oxygen on the range of 5-10% V/V and tensile strengths on the order of 10-
100MPa. Thus as an estimate for the upper limit of oxygen capacity of a 
hyperbarically loaded polymer, one could expect: 
 
 O2 Capacity Hyperbarically Loaded Polymer: 
         
       
             
                      
     
       
             
( IV-1 ) 
 
This is in comparison to the most oxygen dense alternative, calcium peroxide. 
  71 
 
O2 Capacity of Pure Calcium Peroxide: 
 
     
      
         
       
 
   
       
 
   
            
( IV-2 ) 
  
 For a slightly more complicated system, a polymeric foam could be used 
where the polymer phase acts as both the walls of the microtanks as well as the 
structural component of the scaffold. This significantly increases the loading 
efficiency of the system. The oxygen capacity of the foam goes as: 
 
       
                 
                 
        
      
  
( IV-3 ) 
 
Tensile Strength goes as: 
          
    
( IV-4 ) 
 
Thus, for the design of hyperbarically loaded polymeric foams, it is more favorable, 
from an oxygen content perspective, to increase void volume at the expense of 
maximum loading pressure. Obviously, the time constant of release also decreases 
as a function of void volume, so this consideration may impose a limit on void 
volume. A potentially interesting polymer to study from a biomedical perspective is 
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foamed PET as it provides high oxygen barrier, good biocompatibility, and 
comparable mechanical strength to bone. 
 
Product design and applications 
 With tissue engineering likely decades away from becoming mainstream in 
the clinic, it is worthwhile to investigate existing applications that would benefit 
from oxygen delivery technology. A survey of the orthopedic market reveals a large 
number of polymeric implants that may be suitable for hyperbaric loading with 
oxygen. The local delivery of oxygen is anticipated to provide two primary 
therapeutic roles: firstly, preventing infections by increasing the leukocyte 
respiratory burst, and secondly, enhancing the rate of healing through increased 
production of collagen. For applications such as medical fasteners, these two 
properties are very desirable. Figure IV-4 illustrates several of such applications; 
stiches are another potential application. In many cases the fasteners are made from 
nylon, PEEK, or PET which have sufficient oxygen barrier properties to afford a 
period of oxygen release out to two or three weeks. The appeal of such applications 
is that the products already exist, have defined markets, and known utility; thus, the 
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CHAPTER V:  
 
Commercialization and Translation Strategy 
 
 
Defining Target Markets 
 Clinical translation requires a defined, substantial market as well as a developed 
technology. Therefore, in developing a commercial strategy for the technology presented 
within this thesis, one must be cognizant of the present and future markets for oxygen 
delivery as well as the present state and anticipated developments of the microtank 
technology. Figure V-1 summarizes the following analysis.  
 The hyperbaric loading of materials with oxygen represents a novel oxygen 
delivery approach. The approach can be implemented in two distinct ways: the controlled 
outgassing of bulk & foamed polymers or from the controlled release of gas from stand-
alone microtanks. From a technology development perspective, the outgassing of bulk & 
foamed polymers is far more developed, and technologically simpler, than the standalone 
microtanks. Outgassing of bulk polymers & foams has application in at least two distinct 
markets: the medical fastener and the orthopedic scaffold market. Of these, the medical 
fastener market is better established and presents an easier pathway to entry. Regarding 
the markets for stand-alone microtanks, there are applications in wound care and graft 
management as well as within tissue engineering. The market for wound care and graft 
management is very well established, growing, and would be highly receptive to an 
oxygen delivery technology. The tissue engineering market is primarily academic in 
nature and expected to remain so for the next decade. Therefore, from a translation 
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meshes, tapes, and prosthetic ligaments. Medical fasteners inherently cause local damage 
to the tissue during installation including the disruption of local blood supply, volumetric 
bone loss, and occasionally fracture. Two of the most common failure modes for medical 
fasteners are infection and pullout. From a therapeutic perspective, oxygen delivery 
would be beneficial in that the increased collagen deposition would mitigate pullout and 
the enhanced antimicrobial properties would moderate infection. 
 Many medical fasters are now available in polymeric versions, which have the 
advantage of being imaging compatible compared to metallic versions, with some even 
bioresorbable. A survey of medical fasteners indicates a large number are fabricated out 
of polymers suitable for hyperbaric loading with oxygen, namely: polyethylene 
terephthalate (meshes, suture, vascular grafts), polyether ether ketone (suture anchors, 
interference screws, spinal cages, disc arthroplasty, craniofacial implants), polyamide 
(sutures, meshes, foil), and recently polylactide (bioresorbable screws, plates, scaffolds). 
As can be quickly estimated from the graph in Figure V-2, if medical fasteners were 
hyperbarically loaded with oxygen they would be expected to deliver oxygen over a 
period of hours to weeks depending on their geometry. 
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Surgeon are increasingly favoring the use of polymer suture anchors, especially PLA 
models due to their bioresorbable properties. The current 2014 market fixation systems 
for cartilage and soft tissue is estimated at $1.4 billion81, accounting for 75% of the soft 
tissue repair and regenerative product market. It has been growing at a rate of 6% per 
year over the past 4 years driven by favorable demographics and the prevalence of sports-
related injuries.  
 
 
Figure V-3: Smith and Nephew PEEK polymer suture anchors. (L-R) Raptormite, Dynomite, 
Spyromite models. Diameters are 3mm, 2mm, 2mm, respectively. 
 
Other Applications 
 Nylon foil (0.4mm thick nylon sheet) is commonly used in the repair of pediatric 
orbital wall fracture 82 and could benefit from hyperic loading. Other applications that 
may benefit from hyperbaric loading with oxygen are83,84: transcatheter aortic-valve 
implantation, transcatheter aortic-valve replacement, aortic heart valve sewing rings, 
aortic heart valve fabric, mitral valve components, annuloplasty rings, cardiovascular 
patches, embolic protection devices, vascular grafts, coronary artery bypass grafts, stent 
grafts, tapered endovascular grafts, endovascular aneurysm repair, thoracic endovascular 
aneurysm repair, abdominal aortic aneurysm stent grafts, thoracic aortic aneurysm stent 
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grafts, bifurcated endovascular grafts, vascular grafts, embolic protection devices, 
artificial ligaments, artificial tendons, long bone fixation devices, spinal stabilization, 
containment devices, tethers, prosthetic ligaments, pelvic floor repair mesh, incontinence 
slings, hernia mesh, prolapse repair slings, surgical mesh, abdominal wall patches, nerve 
regeneration conduits/ tubes, tissue engineering scaffolds, bio-absorbable scaffolds, stem 
cell platforms, bio-absorbable meshes, hybrid medical fabrics, hernia mesh, surgical 
mesh, abdominal wall patches, breast lift slings, cosmetic surgical mesh, and sutures. 
 
Entry Strategy into Medical Fasteners 
 Consequently, the medical fastener market represents a particularly unique 
opportunity for entry. There are two obvious means of monetizing this technology. 
Firstly, the patented outgassing technology could be licensed directly to the 
manufacturers of these products for hyperbaric loading in-house. This is the simplest 
approach and has the advantage of utilizing the established sales network and 
manufacturing facilities of the company. From the perspective of the company, the 
licensing of the oxygen outgassing technology is beneficial because it allows them to 
differentiate their products from others in a very crowded and stagnant market81. The 
therapeutic benefit of the oxygen makes the pitch to hospitals, clinicians, and patients a 
more tractable one and may allow a premium to be charged.  
 From a licensing perspective, the larger players provide the best opportunity due 
to their broader product lines, R&D budgets, and sales volume. The major players within 
the medical fasteners market are:  
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1. Smith and Nephew – The leading provider of soft tissue and cartilage repair 
products with 22% marketshare (revenues $405 million in 2014). Has substantial 
offerings including anchor systems for shoulder repair, soft tissue repair products 
for the knees and other-extremity soft tissue repair products. S&N’s strong track 
record in the orthopedic industry, together with substantial R&D resourses, are 
predicted to play a major role in its continued success. 
 
2. Arthrex – The second largest player, advancing recently to become a top tier 
provider, with a market share of 22% (revenues $400 million in 2014). It 
specializes in the area of tendon repair, rotator cuff repair, ligament 
reconstruction, meniscal fixation and transplant as well as other areas of the 
cartilage and soft tissue market.  
 
3. Johnson & Johnson / DePuy – Holds the third spot with a marketshare of 12% 
(revenues of $220 million in 2014). It caters to cartilage repair, meniscal repair 
and soft tissue biological implants. DePuy’s comprehensive product line is 
predicted to provide an opportunity for future market leadership. 
 
4. Biomet – With a market share of 10% (revenues of $180 million) ranks fourth. Its 
primary strength is in the fixation device segment. 
 
 Industry reports indicate that the most significant factors increasing market 
position are81,85: 
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 Product cost and price 
 Product design, quality and ease of use 
 Improved patient outcomes  
 Increasing surgeon and physician acceptance 
 Distribution capabilities  
 Patent protection  
 New product innovation timing and market 
Thus hyperbaric outgassing technology makes good strategic sense for these companies. 
Additionally, many of these companies have several divisions that could make similar use 
of the technology. 
 The second approach is to setup a hyperbaric loading company, which would 
charge companies, hospitals, or clinicians a fee for the functionalization of their implants. 
This approach faces logistical complications, as it would require inserting another node 
within the supply chain. It is not a favorable option.  
 
Wound Care & Graft Management 
 The wound care market is a four-tiered market dominated by three major players 
(Johnson and Johnson, Smith and Nephew, and 3M)86 who have been making large 
acquisitions over the past decade, significantly consolidating the market. It includes 
wound dressings, skin replacements, and the like. Acquisitions have primarily involved 
smaller firms with strong R&D pipelines but relatively weak distribution networks. The 
advanced wound care market is valued at $11.3B in 201387 with wound dressings 
accounting for 55% of this market. The trend within the market is a move away from dry 
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dressings towards moist dressings, which are demonstrating enhanced wound healing. 
The major limitation facing companies within the market is the inability to distinguish 
their products from competitors’ products. This has led to efforts to functionalize wound 
dressings with additional features, such as silver particles for antimicrobial properties, but 
there has been a dearth of further meaningful adjuncts to dates. 
 One of the popular adjunctive therapies utilized for advanced wound healing is 
hyperbaric oxygen therapy. Hyperbaric oxygen has been shown to increase healing 
outcomes by 80% through reduced infection, increased vascularization, and tissue 
remodeling. The size of the hyperbaric oxygen market was estimated to be $140 million 
in 200037, however growth was limited by Medicare approved indications. Furthermore, 
the treatment requires the patient to make daily visits to a center, which is time 
consuming and inconvenient. In the 2000 Frost and Sullivan report “Impact of 
Hyperbaric Oxygen Therapy on the U. S. Wound Care Industry” analysts identified 
hyperbaric oxygen therapy to play a major role in the care of diabetic ulcers, an 
indication not yet approved by Medicare. Estimates were that the beneficial effects of 
hyperbaric oxygen applied to the 2006 diabetic foot ulcer market could have had potential 
health savings of $1.4 billion/year. The failure for hyperbaric oxygen therapy to become 
widely adopted despite growing evidence of its benefit is largely due to the method of 
delivery. A means of locally delivering oxygen to a wound without the need for repeat 
trips to a clinic would likely encourage healthcare providers to utilize adjunctive oxygen 
therapy. 
 The development of standalone microtanks that could provide a local supply of 
oxygen to a wound environment would therefore represent a great advance within wound 
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care management. Microtanks could provide both enhanced therapeutic outcomes but 
also a means by which a wound dressing brand could stand out in a crowded market, thus 
meeting the present demands of the market. Hyperbaric therapy currently costs between 
$10,000-40,000 for a course of treatment, giving an indication of the value of the 
therapeutic effect. If local delivery of oxygen by microtanks could provide a comparable 
therapeutic benefit, a large premium could be charged. 
 Stand alone microtanks would also find a market in the field of plastic surgery 
where transplanted grafts are routinely compromised due to local hypoxia as the blood 
supply has been interrupted. The injection of microtanks throughout the graft or coating 
on the surfaces in the case of thin grafts (e.g. skin) could help to mitigate this 
complication. Finally, tissue engineering R&D will remain a small but nontrivial market 
for oxygen delivery technology. R&D applications are advantageous as they provide a 
source of early cash flow without needing to go through the arduous FDA-approval 
process. It is almost certain that if cellularized scaffolds are used within tissue 
engineering, some form of initial oxygen and nutrient augmentation will be required. 
Hopefully, microtanks can fill this niche. 
 
Entry Strategy into Wound Care 
 As a standalone product, microtanks are ideal for a startup company, which can 
produce and initially sell the microtanks directly to researchers interested in combining 
oxygen delivery technology with their current work (e.g. tissue engineering, wound 
repair, transplantation). This beta-testing period will allow sufficient evidence of safety 
and efficacy to be collected to apply for FDA-approval, either directly or by licensing the 
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technology to a larger company. The manufacturing costs associated with microtank 
fabrication, assuming microfluidic approaches are used, are manageable for a small 
company. Furthermore, there exists a range of intermediate production options to 
facilitate scale up.  
 
Intellectual Property Protection 
 Two provisional patent applications were filed with the United States Patent and 
Trademark Office to cover the technology and applications described within this 
document in May, 2013. These have both been converted into Patent Cooperation Treaty 
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